The FDA authorization comes after a late summer rise in cases, at a time the new EG.5 subvariant of Omicron — nicknamed "Eris" — has begun to rapidly spread in the United States
A nurse prepares a booster dose of Pfizer-BioNTech vaccine against coronavirus (COVID-19). (photo credit: MARC ISRAEL SELLEM)ByREUTERSUpdated:
